Who Supplies Pembrolizumab? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Pembrolizumab exports, with 34+ registered manufacturers shipping to buyers across 21+ countries — yet a handful of companies dominate the shipments. GNH INDIA PHARMACEUTICALS LIMITED holds the largest share at 10.6% (export value: $204.6K). Close behind, VAMA LIFECARE PRIVATE LIMITED (9.4%, $181.3K). GEMINI HEALTHWORLD LLP (8.8%, $169.7K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Pembrolizumab? Top Manufacturers & Their Buyers
Flow of Pembrolizumab from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Pembrolizumab Supplier Network — Key Market Intelligence
The Pembrolizumab export market from India is led by GNH INDIA PHARMACEUTICALS LIMITED, which alone commands a 10.6% share, shipping $204.6K worth of product across 6 shipments. The second-largest exporter, VAMA LIFECARE PRIVATE LIMITED, contributes $181.3K (9.4%) to the overall market. Combined, the top two suppliers alone account for 20.0% of all Pembrolizumab exports, indicating a relatively concentrated supply base.
Across all 34 tracked manufacturers, the total Pembrolizumab export value stands at $1.9M from 215 shipments. The market average shipment value is $9.0K. The single largest buyer relationship in terms of trade value is AS PER INVOICE, receiving $105.6K worth of product.
The combined buyer network spans 15 named purchasing companies, including AS PER INVOICE, EXP CODE, EXP CODEE00260 ANANIAS GUILHERME, AS PER INVOICE AS, RICARDO LUIZ BARBOZA and 10 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1GNH INDIA PHARMACEUTICALS LIMITED
GNH INDIA PHARMACEUTICALS LIMITED is the first-largest Pembrolizumab exporter from India, with a market share of 10.6% and a total export value of $204.6K across 6 shipments. Their average shipment value of $34.1K is above the market average of $9.0K, suggesting premium or bulk contract pricing.
GNH INDIA PHARMACEUTICALS LIMITED serves 2 named buyers in our database. TO THE ORDER is the dominant customer, accounting for 61.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER — $124.8K across 4 shipments (61.0% of this supplier's total exports)
• TO THE ORDER — $79.8K across 2 shipments (39.0% of this supplier's total exports)
Key Insight: GNH INDIA PHARMACEUTICALS LIMITED's per-shipment value of $34.1K is 280% above the market average of $9.0K, consistent with large-order contracts or value-added formulations.
2VAMA LIFECARE PRIVATE LIMITED
VAMA LIFECARE PRIVATE LIMITED is the second-largest Pembrolizumab exporter from India, with a market share of 9.4% and a total export value of $181.3K across 19 shipments. Their average shipment value of $9.5K is above the market average of $9.0K, suggesting premium or bulk contract pricing.
VAMA LIFECARE PRIVATE LIMITED serves 4 named buyers in our database. AS PER INVOICE is the dominant customer, accounting for 58.3% of this supplier's tracked business. Top customers include:
• AS PER INVOICE — $105.6K across 11 shipments (58.3% of this supplier's total exports)
• EXP CODE — $29.5K across 3 shipments (16.3% of this supplier's total exports)
• EXP CODEE00260 ANANIAS GUILHERME — $27.5K across 3 shipments (15.2% of this supplier's total exports)
• AS PER INVOICE AS — $18.7K across 2 shipments (10.3% of this supplier's total exports)
Key Insight: VAMA LIFECARE PRIVATE LIMITED's per-shipment value of $9.5K is 6% above the market average of $9.0K, consistent with large-order contracts or value-added formulations.
3GEMINI HEALTHWORLD LLP
GEMINI HEALTHWORLD LLP is the third-largest Pembrolizumab exporter from India, with a market share of 8.8% and a total export value of $169.7K across 26 shipments. Their average shipment value of $6.5K is below the market average of $9.0K, reflecting a high-volume, competitive pricing strategy.
GEMINI HEALTHWORLD LLP serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• RICARDO LUIZ BARBOZA — $47.4K across 7 shipments (28.0% of this supplier's total exports)
• ERINEA FERRAZ DOS — $47.2K across 7 shipments (27.8% of this supplier's total exports)
• ERIKA CARDOSO DA SILVA — $28.2K across 4 shipments (16.6% of this supplier's total exports)
• IGOR ARGEL STECKERT — $28.1K across 4 shipments (16.6% of this supplier's total exports)
• MARIA DAS GRACAS BER — $18.8K across 3 shipments (11.1% of this supplier's total exports)
Key Insight: GEMINI HEALTHWORLD LLP operates with high shipment frequency (26 shipments) at a per-shipment value of $6.5K, indicating a broad distribution network with many smaller, regular orders.
4SHREE KRISHNA LIFECARE
SHREE KRISHNA LIFECARE is the fourth-largest Pembrolizumab exporter from India, with a market share of 8.6% and a total export value of $165.0K across 10 shipments. Their average shipment value of $16.5K is above the market average of $9.0K, suggesting premium or bulk contract pricing.
SHREE KRISHNA LIFECARE serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• KARLENE SMALL — $53.3K across 3 shipments (32.3% of this supplier's total exports)
• KEISHA YOUNG-HENRY — $47.8K across 3 shipments (29.0% of this supplier's total exports)
• TERRENCE FORRESTER — $25.9K across 2 shipments (15.7% of this supplier's total exports)
• KEISHA YOUNG-HENRY — $20.5K across 1 shipments (12.4% of this supplier's total exports)
• PROCUREMENT OFFICER — $17.5K across 1 shipments (10.6% of this supplier's total exports)
Key Insight: SHREE KRISHNA LIFECARE's per-shipment value of $16.5K is 84% above the market average of $9.0K, consistent with large-order contracts or value-added formulations.
5SPECIALITY MEDICINES PRIVATE LIMITED
SPECIALITY MEDICINES PRIVATE LIMITED is the fifth-largest Pembrolizumab exporter from India, with a market share of 7.8% and a total export value of $150.2K across 19 shipments. Their average shipment value of $7.9K is below the market average of $9.0K, reflecting a high-volume, competitive pricing strategy.
SPECIALITY MEDICINES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER — $62.9K across 8 shipments (41.9% of this supplier's total exports)
• TO THE ORDER OF — $55.4K across 7 shipments (36.9% of this supplier's total exports)
• TO THE ORDER OF — $12.9K across 2 shipments (8.6% of this supplier's total exports)
• BETANIA DALBEM DIAS — $9.5K across 1 shipments (6.4% of this supplier's total exports)
• PATIENT BETANIA DALB — $9.5K across 1 shipments (6.4% of this supplier's total exports)
Key Insight: SPECIALITY MEDICINES PRIVATE LIMITED operates with high shipment frequency (19 shipments) at a per-shipment value of $7.9K, indicating a broad distribution network with many smaller, regular orders.
63S PHARMACEUTICALS INDIA PRIVATE LIMITED
3S PHARMACEUTICALS INDIA PRIVATE LIMITED is the fifth-largest Pembrolizumab exporter from India, with a market share of 6.9% and a total export value of $132.5K across 12 shipments. Their average shipment value of $11.0K is above the market average of $9.0K, suggesting premium or bulk contract pricing.
3S PHARMACEUTICALS INDIA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• FOR THE ORDER OF — $38.5K across 3 shipments (29.0% of this supplier's total exports)
• FOR THE ORDER OF PEY — $37.3K across 3 shipments (28.2% of this supplier's total exports)
• FOR THE ORDER OF MAR — $19.1K across 2 shipments (14.4% of this supplier's total exports)
• FOR THE ORDER OF FRA — $19.1K across 2 shipments (14.4% of this supplier's total exports)
• FOR THE ORDER OF PEY — $18.5K across 2 shipments (13.9% of this supplier's total exports)
Key Insight: 3S PHARMACEUTICALS INDIA PRIVATE LIMITED's per-shipment value of $11.0K is 23% above the market average of $9.0K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Pembrolizumab Flows
Once Pembrolizumab leaves the manufacturing plants of companies like GNH INDIA PHARMACEUTICALS LIMITED and VAMA LIFECARE PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $1.9M. Brazil absorbs the largest share at 44.6% ($860.1K), followed by Zimbabwe (8.5%) and Maldives (8.4%).
In Brazil — the top destination — named importers include AS PER INVOICE, F AGAINST PROFORMA INVOICE, RICARDO LUIZ BARBOZA.
This geographic spread reflects Pembrolizumab's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Pembrolizumab Go? Top Importing Countries & Their Buyers
Trade flow of Pembrolizumab exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Brazil
Brazil ranks as the first-largest destination for Pembrolizumab imports from India, with a total trade value of $860.1K across 41 shipments — representing a 44.6% share of all Pembrolizumab exports. The average shipment value of $21.0K is above the global average of $9.0K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.
Named Pembrolizumab importers in Brazil: AS PER INVOICE is the largest buyer, accounting for 12.3% ($105.6K) of this market's total imports.
• AS PER INVOICE — $105.6K (12.3% of Brazil's total)
• F AGAINST PROFORMA INVOICE — $48.9K (5.7% of Brazil's total)
• RICARDO LUIZ BARBOZA — $47.4K (5.5% of Brazil's total)
Key Insight: Brazil's per-shipment average of $21.0K (134% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Pembrolizumab imports from India.
2Zimbabwe
Zimbabwe ranks as the second-largest destination for Pembrolizumab imports from India, with a total trade value of $163.5K across 0 shipments — representing a 8.5% share of all Pembrolizumab exports. The average shipment value of $163.5K is above the global average of $9.0K, indicating high-value procurement contracts or branded formulations.
Key Insight: Zimbabwe's per-shipment average of $163.5K (1721% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Zimbabwe is a key market for Pembrolizumab imports from India.
3Maldives
Maldives ranks as the third-largest destination for Pembrolizumab imports from India, with a total trade value of $161.9K across 30 shipments — representing a 8.4% share of all Pembrolizumab exports. The average shipment value of $5.4K is below the global average of $9.0K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Pembrolizumab importers in Maldives: INDIRA GANDHI MEMORIAL HOSPITAL is the largest buyer, accounting for 80.4% ($130.1K) of this market's total imports.
• INDIRA GANDHI MEMORIAL HOSPITAL — $130.1K (80.4% of Maldives's total)
Key Insight: Maldives receives frequent, smaller shipments of Pembrolizumab — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Maldives is a key market for Pembrolizumab imports from India.
4Jamaica
Jamaica ranks as the fourth-largest destination for Pembrolizumab imports from India, with a total trade value of $161.5K across 4 shipments — representing a 8.4% share of all Pembrolizumab exports. The average shipment value of $40.4K is above the global average of $9.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Pembrolizumab importers in Jamaica: KARLENE SMALL is the largest buyer, accounting for 33.0% ($53.3K) of this market's total imports.
• KARLENE SMALL — $53.3K (33.0% of Jamaica's total)
• KEISHA YOUNG-HENRY — $47.8K (29.6% of Jamaica's total)
Key Insight: Jamaica's per-shipment average of $40.4K (350% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Jamaica is a key market for Pembrolizumab imports from India.
5Georgia
Georgia ranks as the fifth-largest destination for Pembrolizumab imports from India, with a total trade value of $150.4K across 6 shipments — representing a 7.8% share of all Pembrolizumab exports. The average shipment value of $25.1K is above the global average of $9.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Pembrolizumab importers in Georgia: MERMISI LLC is the largest buyer, accounting for 39.8% ($59.9K) of this market's total imports.
• MERMISI LLC — $59.9K (39.8% of Georgia's total)
Key Insight: Georgia's per-shipment average of $25.1K (179% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Georgia is a key market for Pembrolizumab imports from India.
People Also Ask — Pembrolizumab Supplier & Trade Network
Who are the top suppliers of Pembrolizumab from India?+
Which companies buy Pembrolizumab from Indian manufacturers?+
Where does Pembrolizumab exported from India go?+
What is the market share of the top Pembrolizumab supplier from India?+
What is the average shipment value for Pembrolizumab exports from India?+
Is Pembrolizumab manufactured in India and exported globally?+
Which country imports the most Pembrolizumab from India?+
Who are the buyers of Pembrolizumab in Zimbabwe?+
How concentrated is the Pembrolizumab supplier market in India?+
How do I find verified buyers for Pembrolizumab in specific countries?+
Pembrolizumab Trade Network — Key Takeaways
- 1GNH INDIA PHARMACEUTICALS LIMITED is India's dominant Pembrolizumab exporter with a 10.6% market share and $204.6K in total exports — making it the single most important sourcing entity in this market.
- 2The top 34 suppliers collectively account for 52.0% of all tracked Pembrolizumab exports, with a combined trade value of $1.9M.
- 3Brazil is the largest destination market, absorbing 44.6% of India's Pembrolizumab exports ($860.1K). Zimbabwe (8.5%) and Maldives (8.4%) follow.
- 4With 215 total shipments averaging $9.0K each, the Pembrolizumab export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AS PER INVOICE, EXP CODE, RICARDO LUIZ BARBOZA, ERINEA FERRAZ DOS — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 2 customers
6 suppliers → 21 countries
Network value: $1.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pembrolizumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Pembrolizumab.
- 2.Flow Mapping: 34 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 215 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 21 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
215 Verified Shipments
34 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists